The incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades. Currently, between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. In this study, we proposed an ensemble CNNs for multi-class classification study based on integration of image preprocess, deep learning and risk management on skin cancer dermoscopy images with Meta-data. We basically demonstrate general stacking ensemble flow by stages from data preprocessing, CNNs grouping, Meta-data concatenating and 1st CNNs ensemble and 2nd meta-classifiers ensemble. Our result showed good performance, especially the contribution from 1st ensemble while we check break-down details. With our 5% holdout validation dataset, we saw accuracy maximum 91% in our ensemble model, compared with best single CNN (DenseNet121) 87.3%. Furthermore, we also introduced cost adjustment analysis in ensemble phase to manipulate different risk management trade-off strategy for specific categories or metrics, rather than in deep learning phase, so that no need to retrain CNN via loss function adjustment.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: